| UNITED STATES | OMB APPROVAL | |||
| SECURITIES AND EXCHANGE COMMISSION | OMB Number: 3235-0101 | |||
| Washington, D.C. 20549 | Expires: December 31, 2009 | |||
| Estimated average burden | ||||
| FORM 144 | hours per response ......... 2.00 | |||
|
NOTICE OF PROPOSED SALE OF SECURITIES |
SEC USE ONLY | |||
|
PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 |
DOCUMENT SEQUENCE NO. | |||
|
ATTENTION:
Transmit for filing 3 copies of this form concurrently with either
placing |
CUSIP NUMBER | |||
|
an order with a broker to execute sale or executing a sale directly with a market maker. |
||||
|
I (a) NAME OF ISSUER (Please type or print) SYNTA PHARMACEUTICALS CORPORATION |
(b) IRS IDENT. NO. | (c) S.E.C. FILE NO. | WORK LOCATION | |
| 1 (d) ADDRESS OF ISSUER | STREET | CITY | STATE | ZIP CODE | (e) TELEPHONE NO. | ||
| AREA CODE | NUMBER | ||||||
| 45 | HARTWELL AVENUE, | LEXINGTON | MA | 02421 | |||
|
2 (a) NAME OF PERSON
FOR WHOSE ACCOUNT THE SECURITIES ARE TO BE SOLD |
(b) RELATIONSHIP
TO ISSUER |
(c) ADDRESS STREET | CITY | STATE | ZIP CODE | |
| GALLEON TECHNOLOGY OFFSHORE, Ltd. | NONE | 590 MADISON AVE., 34th, FL | NY | NY | 10022 |
| INSTRUCTION: The person filing this notice should contact the issuer to obtain the I.R.S. Identification Number and the S.E.C. File Number. |
| 3 (a) | (b) | SEC USE ONLY | (c) | (d) | (e) | (f) | (g) |
|
Title of the Class of Securities To Be Sold |
Name and Address of
Each Broker Through Whom the Securities are to be Offered or Each Market Maker who is Acquiring the Securities |
Broker-Dealer File Number |
Number of
Shares |
Aggregate |
Number of
Shares |
Approximate |
Name of Each |
| COMMON |
KNIGHT EQUITY MARKETS, L.P. 545 WASHINGTON BOULEVARD JERSEY CITY, NEW JERSEY 07310 |
13,577 | 110,657.98 | 33,832,198 | 11/9/07 | NASDAQ | |
| INSTRUCTIONS: | 3. | (a) | Title of the class of securities to be sold | ||
| 1. | (a) (b) |
Name of
issuer Issuer’s I.R.S. Identification Number |
(b) | Name and address of each
broker through whom the securities are intended to be sold |
|
| (c) (d) |
Issuer’s S.E.C. file
number, if any Issuer’s address, including zip code |
(c) | Number of shares or other
units to be sold (if debt securities, give the aggregate face amount) |
||
| (e) | Issuer’s telephone number, including area code | (d) | Aggregate market value of
the securities to be sold as of a specified date within 10 days prior to the filing of this notice |
||
| (e) | Number of shares or other
units of the class outstanding, or if debt securities the face amount thereof outstanding, as shown by the most recent report or statement published by the issuer |
||||
| |
(f) (g) |
Approximate
date on which the securities are to be sold Name of each securities exchange, if any, on which the securities are intended to be sold |
|||
| 2. | (a) (b) |
Name of person for whose
account the securities are to be sold Such person’s relationship to the issuer (e.g., officer, director, 10% stockholder, or member of immediate family of any of the foregoing) |
|||
| (c) | Such person’s address, including zip code | ||||
|
|
Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | |
|
|
| TABLE I — SECURITIES SOLD TO BE SOLD |
| Furnish
the following information with respect to the acquisition of the securities to be
sold and with respect to the payment of all or any part of the purchase price or other consideration therefor: |
| Title of the Class | Date You Acquired | Nature of Acquisition Transaction |
Name of Person from Whom
Acquired (If gift, also give date donor acquired) |
Amount of Securities Acquired |
Date of Payment |
Nature of Payment |
| COMMON | 6/2/06 |
GALLEON TECHNOLOGY
OFFSHORE, Ltd. PURCHASED SERIES A CONVERTIBLE PREFERRED STOCK ON JUNE 2,2006. THE COMPANY CONVERTED THE SERIES A ON FEB. 9, 2007 TO COMMON IN CONNECTION WITH THE IPO. |
SYNTA PHARMACEUTICALS CORPORATION |
13,577 | 6/2/06 | CASH |
| INSTRUCTIONS: |
If the securities were
purchased and full payment therefor was not made in cash at the time of
purchase, explain in the table or in a note thereto the nature of the
consideration given. If the consideration consisted of any note or
other obligation, or if payment was made in installments describe the
arrangement and state when the note or other obligation was discharged in
full or the last installment paid.
|
| TABLE II — SECURITIES SOLD DURING THE PAST 3 MONTHS |
| Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold. |
| Name and Address of Seller | Title of Securities Sold | Date of Sale |
Amount of
Securities Sold |
Gross Proceeds |
|
GALLEON TECHNOLOGY
OFFSHORE, Ltd.
|
COMMON | OCT. 10, 2007 | 48,750 | $460,861 |
| REMARKS: | ||
| INSTRUCTIONS: | ATTENTION: | |
|
See the definition of
“person” in paragraph (a) of Rule 144. Information is to
be given not only as to the person for whose account the securities are to
be sold but also as to all other persons included in that definition.
In addition, information shall be given as to sales by all persons
whose sales are required by paragraph (e) of Rule 144 to be aggregated with
sales for the account of the person filing this notice.
|
The person for whose
account the securities to which this notice relates are to be sold hereby
represents by signing this notice that he does not know any material
adverse information in regard to the current and prospective operations of
the Issuer of the securities to be sold which has not been publicly
disclosed.
|
| NOVEMBER 13, 2007 | /S/ CAROLYN A. MILLER | |||||
| DATE OF NOTICE | (SIGNATURE) | |||||
| The
notice shall be signed by the person for whose account the securities are to be
sold. At least one copy of the notice shall be manually signed.
Any copies not manually signed shall bear typed or printed signatures. |
| ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001) |
|
|